premargin

Element List	Explanation
Introduction	The Board of Directors of Modern Miral Medical Clinics Company is pleased to invite the esteemed shareholders of the company to vote in the General Assembly (first meeting) and to decide on contracting with it via technological means, God willing, at (19:15) on Monday, 22/12/1447 AH, corresponding to 08/06/2026 AD.
City and Location of the General Assembly's Meeting	The company's headquarters are located in Riyadh – Al Olaya District – Al Tahlia Street – and this is done through modern technology.
Hyperlink of the Meeting Location	Click Here
Date of the General Assembly's Meeting	2026-06-08 Corresponding to 1447-12-22
Time of the General Assembly’s Meeting	19:15
Methodology of Convening the General Assembly’s Meeting	Via modern technology means
Attendance Eligibility, Registration Eligibility, and Voting End	Shareholders who are registered in the issuers shareholders record at the Depositary Center by the end of the trade session prior to the general assembly meeting and in accordance with the laws and regulations. The shareholder has the right to delegate whomever other than the board of directors. The right to register a name to attend the general assembly meeting ends at the time of convening the general assembly meeting. The attendees right to vote on the items of the assembly’s agenda ends upon the end of screening the votes by the Screening Committee.
Quorum for Convening the General Assembly's Meeting	According to Article (33) of the company’s Articles of Association, the ordinary general assembly meeting shall not be valid unless it is attended by shareholders representing at least one-quarter of the company’s shares that have voting rights. If this quorum is not met at the first meeting, the second meeting shall be held one hour after the end of the time specified for the first meeting. In all cases, the second meeting shall be considered valid regardless of the number of shares that have voting rights represented at it.
General Assembly Meeting Agenda	1. Vote on the company's auditor's report for the fiscal year ending December 31, 2025, after discussion. 2. Review and discuss the Board of Directors' report for the fiscal year ending December 31, 2025. 3. Review and discuss the company's financial statements for the fiscal year ending December 31, 2025. 4. Vote on the discharge of the Board of Directors from liability for the fiscal year ending December 31, 2025. 5. Vote on the appointment of an auditor for the company from among the nominees, based on the recommendation of the Audit Committee, to examine, review, and audit the company's interim financial statements for the first quarter ending March 31, 2026, the second quarter ending June 30, 2026, the third quarter ending September 30, 2026, and the annual financial statements ending December 31, 2026, and determine their fees. 6- Voting on authorizing the Board of Directors to distribute interim dividends to shareholders on a semi-annual or quarterly basis for the fiscal year ending December 31, 2026. 7- Voting on authorizing the Board of Directors with the powers of the Ordinary General Assembly to grant the authorization stipulated in paragraph (1) of Article Twenty-Seven of the Companies Law, for a period of one year from the date of approval by the General Assembly or until the end of the term of the authorized Board of Directors, whichever is earlier, in accordance with the conditions stipulated in the Implementing Regulations of the Companies Law pertaining to listed joint-stock companies. 8- Voting on the transactions and contracts concluded between the company and the CEO and Managing Director (Dr. Sami Abdullah Al-Saeed), in which he has a direct interest, consisting of (salaries, commissions, and bonuses). These transactions commenced in 2025, with a total value of SAR 1,244,957 during that year. These transactions are conducted within the normal course of business and in accordance with prevailing commercial terms and conditions, without any preferential terms (attached). 9- Voting on amending the policy and criteria for remuneration of members of the Board of Directors, its subcommittees, and the executive management (attached).
Proxy Form	Proxy Form
The shareholder right in discussing the assembly agenda topics, asking questions, and exercising the voting right	Shareholders are entitled to discuss the topics included in the agenda of the Ordinary General Assembly and to ask questions. Voting through the Tadawulaty services is available free of charge to all shareholders using the following link: http://www.tadawulaty.com.sa
Details of the electronic voting on the Assembly’s agenda	Shareholders registered with Tadawulaty services can vote electronically and remotely on the General Assembly's agenda items starting at 1:00 AM on Thursday, December 18, 1447 AH (June 4, 2026), until the end of the General Assembly meeting. Registration and voting through Tadawulaty services will be available free of charge to all shareholders using the following link: www.tadawulaty.com.sa
Method of Communication in Case of Any Enquiries	We welcome your inquiries through our Shareholder Relations department via the following channels: Phone: 0114620444 Email: investors@miraldental.com
Attached Documents	Attached Documents

Miral Dental Clinics Co. Board invites its shareholders to attend the Ordinary General Assembly Meeting the (First Meeting)